SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Vivimed Labs informs about revised AGM proceedings

07 Oct 2025 Evaluate
Vivimed Labs has informed that 37th Annual General Meeting (AGM) of the members of Vivimed Labs ('the Company') has been duly convened and held on Tuesday, 30th September, 2025 at 03:00 pm through Video Conferencing in accordance with the applicable provisions of the Companies Act, 2013 read with MCA Circulars and SEBI Circulars to transact the business as stated in the Notice dated 13th August 2025, convening the AGM. In this regard enclosed the following: 1) Summary of the proceedings of the AGM of the Company as required under Regulation 30, Part-A of Schedule-III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Annexure-I. 

The above information is a part of company’s filings submitted to BSE.

Vivimed Labs Share Price

7.06 0.33 (4.90%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×